Evidence‐based <scp>C</scp>linical <scp>P</scp>ractice <scp>G</scp>uidelines for <scp>H</scp>epatocellular <scp>C</scp>arcinoma: The <scp>J</scp>apan <scp>S</scp>ociety of <scp>H</scp>epatology 2013 update (3rd <scp>JSH‐HCC G</scp>uidelines)
-
- Norihiro Kokudo
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Kiyoshi Hasegawa
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Masaaki Akahane
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Hiroshi Igaki
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Namiki Izumi
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takafumi Ichida
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shinji Uemoto
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shuichi Kaneko
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Seiji Kawasaki
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Yonson Ku
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Masatoshi Kudo
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shoji Kubo
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Tadatoshi Takayama
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Ryosuke Tateishi
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takashi Fukuda
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Osamu Matsui
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Yutaka Matsuyama
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Takamichi Murakami
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Shigeki Arii
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Masatoshi Okazaki
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
-
- Masatoshi Makuuchi
- The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma Tokyo Japan
抄録
<jats:p>The 3rd version of <jats:styled-content style="fixed-case">C</jats:styled-content>linical <jats:styled-content style="fixed-case">P</jats:styled-content>ractice <jats:styled-content style="fixed-case">G</jats:styled-content>uidelines for <jats:styled-content style="fixed-case">H</jats:styled-content>epatocellular <jats:styled-content style="fixed-case">C</jats:styled-content>arcinoma was revised by the <jats:styled-content style="fixed-case">J</jats:styled-content>apan <jats:styled-content style="fixed-case">S</jats:styled-content>ociety of <jats:styled-content style="fixed-case">H</jats:styled-content>epatology, according to the methodology of evidence‐based medicine, which was published in <jats:styled-content style="fixed-case">O</jats:styled-content>ctober 2013 in Japanese. Here, we briefly describe new or changed recommendations with a special reference to the two algorithms for surveillance, diagnosis, and treatment.</jats:p>
収録刊行物
-
- Hepatology Research
-
Hepatology Research 45 (2), 123-, 2015-01
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360846643093103616
-
- ISSN
- 1872034X
- 13866346
-
- データソース種別
-
- Crossref
- KAKEN